You searched for "lesion"
Results of fixed aflibercept treatment regime in type 3 neovascularisation
In this prospective study the authors evaluate the effect of intravitreal aflibercept injections in the treatment of naive type 3 neovascularisation using a fixed treatment regime. Fourteen eyes of 14 patients were studied. All patients were treated with intravitreal 2.0...
Microvasculature changes of mCNV after ranibizumab treatment using OCTA
In this study the authors aim to evaluate the vascular changes of myopic choroidal neovascularisation (mCNV) after ranibizumab treatment using optical coherence tomography-angiography (OCTA). The 3×3 OCTA en face images were analysed for the absence / presence of mCNV, CNV...Scope Ophthalmology announce case awards winners
Scope Eyecare are delighted to announce the winners of the Scope Ophthalmology case awards UK and Ireland for 2023.
The natural history of treatment naïve choroidal neovascularisation (CNV) in geographic atrophy
The aim of this retrospective study is to assess the characteristics and natural history of quiescent CNV in geographic atrophy (GA) utilising multi-modal imaging. Case notes were reviewed of patients diagnosed with geographic atrophy between January 2010 and December 2016...Strengthening capacity for ophthalmic research within three East African VISION 2020 LINKS – The Research Mentorship Workshop
Building capacity for ophthalmic research in low- and middle-income countries is an important aim of the VISION 2020 LINKS Programme. The International Centre for Eye Health (ICEH) at the London School of Hygiene & Tropical Medicine (LSHTM) has been working...
Driving with the use of spectacle mounted telescopes (bioptics)
The authors discuss the current perspectives of spectacle mounted telescopes (bioptics) whilst driving among patients with visual impairment. The history, design and driving laws surrounding the use of bioptics is discussed in detail. In 1977, William Feinbloom developed a bioptic...Quiz Apr/May 2023
History A 76-year-old female presented at her local district general hospital with right decreased visual acuity, glare, and foreign body sensation, in addition to longer-term dry eyes. She was otherwise well. Her past medical history included hypertension. On examination: vision...Vision Buddy: A sight enhancement wearable to enhance TV and computer viewing
This review of the Vision Buddy system continues our recent series on wearable assistive technology. The main component of the Vision Buddy system is a VR-type headset, designed to assist users with a range of tasks primarily within the home...Assessing everyday visual function in dry AMD – what matters to the person?
Age-related macular degeneration (AMD) is the primary cause of blindness in the developed world and is accountable for more than one half of sight impairment registrations within England and Wales [1]. AMD is prevalent in people aged 60 years and...In conversation with Professor Bernie Chang, President, Royal College of Ophthalmologists
Congratulations on your appointment as RCOphth President in May last year. COVID-19 hit just before your presidency started. This must have been an incredibly challenging time to take the reins. How has the College risen to the challenges? Thank you....UK Glaucoma Fellows Meeting 2023
09:00 - 09:30 Welcome 09:30 - 09:45 Introduction: Mr. Imran Masood (Participants split into 4 small groups, then cycle around the sessions) 10:00 – 13:00 Session 1 Introducing new technologies to NHS trusts Imran Masood Session 2 Optimising Patient Safety...
